摘要
目的:评价盐酸曲美他嗪治疗冠心病稳定型心绞痛的预后效果。方法:选择我院2016~2018年期间收治的80例冠心病稳定型心绞痛患者,随机分为常规抗心绞痛综合治疗的对照组以及加行盐酸曲美他嗪治疗的观察组。结果:观察组患者治疗总有效率高于对照组,指标结果优于对照组,腹痛、腹泻不良反应差异显著,P>0.05。结论:冠心病稳定型心绞痛治疗期间加行盐酸曲美他嗪治疗效果显著。
Objective:To evaluate the prognostic effect of trimetazidine hydrochloride in the treatment of coronary heart disease stable angina pectoris.Methods:80 patients with stable angina pectoris treated in our hospital from 2016 to 2018 were randomly divided into the control group with conventional anti-angina pectoris and the observation group treated with adding trimetazidine hydrochloride.Results:The total effective rate of the observation group was higher than that of the control group.The index results were superior to the control group.The adverse reactions of abdominal pain and diarrhea were significant,P>0.05.Conclusion:The effect of adding trimetazidine hydrochloride during the treatment of stable angina pectoris is significant.
作者
黄国强
胡彩霞
姜建党
Huang Guoqiang;Hu Caixia;Jiang Jiandang(Weishi County People's Hospital,Kaifeng 475500)
出处
《数理医药学杂志》
2020年第3期420-421,共2页
Journal of Mathematical Medicine
关键词
盐酸曲美他嗪
冠心病稳定型心绞痛
症状体征
治疗效果
trimetazidine hydrochloride
coronary heart disease stable angina pectoris
symptoms and signs
treatment effect